Bausch Health Companies (BHC) Current Taxes (2009 - 2012)
Bausch Health Companies (BHC) reported Current Taxes of $14.4 million for Q4 2012, up 47.67% on a YoY basis from $9.7 million in Q1 2012, and up 41.02% sequentially from $10.2 million in Q3 2012.
Bausch Health Companies (BHC) Current Taxes (2009 - 2012) Analysis & Trends
Bausch Health Companies (BHC) has 4 years of Current Taxes data on file, last reported at $14.4 million in Q4 2012.
- For the quarter ending Q4 2012, Current Taxes rose 47.67% year-over-year to $14.4 million; the trailing twelve-month figure through Dec 2012 stood at $14.4 million (up 47.67% YoY), and the FY2012 full-year result was $14.4 million, up 47.67% from the prior year.
- Current Taxes grew to $14.4 million in Q4 2012, from $10.2 million in the prior quarter.
- In the past five years, Current Taxes ranged from a high of $41.6 million in Q3 2011 to a low of $646000.0 in Q4 2010.
- A 4-year average of $11.3 million and a median of $10.0 million in 2011 frame the typical range for Current Taxes.
- Across the five-year window, Current Taxes tumbled 94.29% in 2011 and soared 2305.11% in 2012, its largest moves.
- Tracing BHC's Current Taxes over 4 years: stood at $6.8 million in 2009, then slumped by 90.56% to $646000.0 in 2010, then jumped by 1408.98% to $9.7 million in 2011, then jumped by 47.67% to $14.4 million in 2012.
- Business Quant data shows BHC's Current Taxes at $14.4 million in Q4 2012, $10.2 million in Q3 2012, and $15.5 million in Q2 2012.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 355.15 Mn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 211.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 624.14 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 640.78 Mn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Bausch Health Companies | 1.66 Bn | 1.33 Bn | 2.52 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2012 | 14.40 Mn |
| Sep 30, 2012 | 10.21 Mn |
| Jun 30, 2012 | 15.54 Mn |
| Mar 31, 2012 | 8.25 Mn |
| Dec 31, 2011 | 9.75 Mn |
| Sep 30, 2011 | 41.64 Mn |
| Jun 30, 2011 | 646,000.00 |
| Mar 31, 2011 | 646,000.00 |
| Dec 31, 2010 | 646,000.00 |
| Sep 30, 2010 | 15.26 Mn |
| Jun 30, 2010 | 11.32 Mn |
| Dec 31, 2009 | 6.85 Mn |